Aehr Test Systems Soared 21.2% Intraday—Is This the Dawn of AI-Driven Semiconductor Supercycle?

Summary
• Aehr Test Systems (AEHR) surged 21.2% to $19.95, hitting its 52-week high of $21.81
• Company announced eight Sonoma systems for AI processor production burn-in with a top hyperscaler
• Intraday volume spiked to 5.7 million shares, exceeding 20.6% of its float
• Sector leader Teradyne (TER) lagged with -2.1% decline despite broader semiconductor optimism

Aehr Test Systems is rewriting its narrative with a jaw-dropping intraday rally fueled by blockbuster orders from a leading AI hyperscaler. The stock’s 21.2% surge—its most volatile session in years—positions it at a critical inflection point as the AI semiconductor market accelerates. With the Sonoma systems now central to a customer’s AI processor scaling plans, investors are recalibrating their risk appetite for this niche but explosive segment of the semiconductor value chain.

Sonoma Systems Powerhouse Orders Ignite AI Semiconductor Revolution
Aehr Test Systems’ meteoric rise stems from a landmark order for eight Sonoma ultra-high-power systems from a world-leading hyperscaler. These systems, tailored for AI processor production burn-in, signify a 'more than doubling' of existing orders with the customer and validate Aehr’s pivot into the AI-driven semiconductor market. The hyperscaler’s commitment to scaling its AI processor capacity—backed by Aehr’s proprietary liquid-cooled burn-in technology—has triggered a re-rating of the stock’s growth potential. With AI chip demand projected to grow 30% annually through 2032, Aehr’s role in enabling early-life failure detection for high-power AI chips has positioned it as a critical enabler of the next computing frontier.

Semiconductor Equipment Sector Gains Momentum as AI Spending Surges
The broader semiconductor equipment sector is rallying on AI-driven capital expenditures, with SEMI forecasting $125.5 billion in 2025 equipment sales—a 7.4% year-on-year increase. Aehr’s 21.2% move outpaces sector leader Teradyne’s (-2.1%) decline, highlighting its unique exposure to AI-specific test solutions. While Teradyne dominates in general semiconductor test, Aehr’s Sonoma platform is engineered for the extreme power and thermal demands of AI processors, creating a differentiated value proposition in a $600 billion AI chip market by 2032. This divergence underscores the sector’s bifurcation between traditional and AI-focused players.

Options Volatility Spikes—How to Leverage AEHR’s Breakout with Precision
• 200-day average: $11.57 (below current price)
• RSI: 65.8 (neutral to overbought)
• MACD: 1.08 (bullish divergence)
• Bollinger Bands: Price at $19.95 vs. upper band $16.83 (strong break above)
• Kline pattern: Short-term bullish engulfing pattern confirmed

Aehr’s technicals scream breakout potential. The stock has pierced its 52-week high of $21.81, with RSI in overbought territory and MACD expanding above the signal line. The bullish engulfing candlestick pattern suggests momentum is accelerating. For options traders, the AEHR20250815C20 and AEHR20250919C20 contracts stand out. The August 20 call (AEHR20250815C20) offers 10.76% leverage and 89.8% implied volatility, with high gamma (0.0847) and theta (-0.0528) suggesting rapid price sensitivity. The September 20 call (AEHR20250919C20) provides 7.96% leverage and 77.2% IV, with a 224.68% price gain to date. Both options are liquid (turnover $584k and $249k) and align with the stock’s 21.2% intraday move. For a 5% upside scenario (target $20.94), the August 20 call yields a 54.7% payoff, while the September 20 call delivers 28.2%. Aggressive bulls should consider these contracts into a $20.50 pivot, while capping risk at $19.50 support.

Backtest Aehr Test Systems Stock Performance
The 21% intraday surge in AEHR has historically led to positive short-to-medium-term gains. The backtest data shows that following such a significant increase:1. Short-Term Gains: The 3-day win rate is 53.95%, indicating that over half of the time, the stock continues to rise in the three days following the intraday surge.2. Medium-Term Gains: The 10-day win rate is 52.41%, suggesting a high probability of continued growth in the ten days following the surge.3. Long-Term Gains: The 30-day win rate is 55.67%, with the maximum return observed at 22.46% over 30 days, indicating that the stock tends to maintain its momentum over longer periods.In conclusion, an intraday surge of 21% in AEHR has a strong likelihood of being followed by gains in the subsequent days, making it a potentially favorable entry point for investors looking to capitalize on short-to-medium-term movements. However, it's important to consider other factors and market conditions before making investment decisions.

Aehr’s AI Inflection Point—Act Fast on This Semiconductor Superstock
Aehr Test Systems has ignited a technical and fundamental catalyst that could redefine its valuation. The Sonoma order backlog, coupled with AI’s 30% CAGR tailwind, creates a powerful flywheel for revenue growth. While the stock’s 21.2% move has already triggered a 52-week high retest, the broader semiconductor equipment sector—led by $125.5 billion in 2025 equipment demand—provides fertile ground for further gains. Investors should monitor the $20.50 resistance level and watch sector leader Teradyne (TER) for cross-sector confirmation. With AI’s $600 billion endgame in sight, Aehr’s niche in high-power test solutions is a must-own for those positioned to capitalize on the next computing revolution. The window is narrow—act before the AI semiconductor frenzy fades.